Download presentation
Presentation is loading. Please wait.
Published byAlbert Lambert Modified over 9 years ago
1
Quantitative modeling of chronic myeloid leukemia: insights from radiobiology by Tomas Radivoyevitch, Lynn Hlatky, Julian Landaw, and Rainer K. Sachs Blood Volume 119(19):4363-4371 May 10, 2012 ©2012 by American Society of Hematology
2
Cell population dynamic CML models. Tomas Radivoyevitch et al. Blood 2012;119:4363-4371 ©2012 by American Society of Hematology
3
TKI discontinuation possibilities illustrate deterministic versus stochastic modeling differences. Tomas Radivoyevitch et al. Blood 2012;119:4363-4371 ©2012 by American Society of Hematology
4
CML latency time T. T is here considered as a random variable, that is, a quantity described by a probability density because it may fluctuate from case to case in a way not (yet) fully predictable. Tomas Radivoyevitch et al. Blood 2012;119:4363-4371 ©2012 by American Society of Hematology
5
Atomic bomb survivor waiting times. Tomas Radivoyevitch et al. Blood 2012;119:4363-4371 ©2012 by American Society of Hematology
6
Age dependence of background CML incidence and translocation prevalence. Tomas Radivoyevitch et al. Blood 2012;119:4363-4371 ©2012 by American Society of Hematology
7
CML incidence versus age at radiation exposure for different dose groups. Tomas Radivoyevitch et al. Blood 2012;119:4363-4371 ©2012 by American Society of Hematology
8
Proximity effects. Tomas Radivoyevitch et al. Blood 2012;119:4363-4371 ©2012 by American Society of Hematology
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.